Our data might suggest a particular causal contribution of ATM lipid content and adipose tissue foam cells to NAFLD, possibly beyond classical inflammatory activation of the ATM, consistent with previous reports (Xu et al. 2013, Kratz et al. 2014). The gene discussed is ATM; the disease is metabolic dysfunction-associated steatotic liver disease.